An evidence map of randomised controlled trials evaluating genetic therapies
Eric Apaydin(RAND Corporation), Susanne Hempel, Gulrez Shah Azhar(RAND Corporation), Andrea S. Richardson(Brigham and Women's Hospital), Jerry Vockley(Pittsburgh Public Schools), Olamigoke Akinniranye(RAND Corporation), Aneesa Motala(University of Southern California), Jody Larkin(RAND Corporation), Rachel Ross(RAND Corporation), Sangita M. Baxi(Pfizer (United States))
Cited by 10
Related Papers
Molecular characterization of the tumor microenvironment in breast cancer
|Cancer Cell|2004|1.3k
Phenylalanine hydroxylase deficiency: diagnosis and management guideline
|Genetics in Medicine|2014|718
Effects of Diet and Physical Activity Interventions on Weight Loss and Cardiometabolic Risk Factors in Severely Obese Adults
|JAMA|2010|554
Comparative Effectiveness of Pharmacologic Treatments to Prevent Fractures
|Annals of Internal Medicine|2014|256
Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation
|Proceedings of the National Academy of Sciences|1998|254